Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...

Concepts announced the successful completion of the first cases utilizing its SpeedAkin Anatomic Compression Implant, ...

Treace Medical Concepts, Inc.’s TMCI share price has surged by 10.21%, which has investors questioning if this is right time ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Treace Medical Concepts Trading Up 5.6 % NASDAQ TMCI opened at $8.71 on Friday. Treace Medical Concepts, Inc. has a one year low of $3.92 and a one year high of $15.98. The firm has a market cap ...

1 Day TMCI -4.19% DJIA 0.52% Russell 2K 1.13% Health Care/Life Sciences 0.39% ...

Treace, CEO, Founder and Board Member of Treace. “Driven by our active pipeline of differentiated technologies, we are excited to enter 2025 with multiple innovative product launches ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com.

as well as other common bone fusion procedures of the foot. For more information, please visit www.treace.com. DOWNLOAD THE DIGITAL EDITION APP ...